2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
187
Myelodysplastic Syndromes
82
Leukemia
39
Leukemia, Myelomonocytic, Chronic
36
Recurrence
24
Myeloproliferative Disorders
15
Congenital Abnormalities
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Large B-Cell, Diffuse
13
Neoplasms
11
Primary Myelofibrosis
9
Melanoma
9
Blast Crisis
9
Thrombocythemia, Essential
7
Polycythemia Vera
7
Leukemia, Myelomonocytic, Acute
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Monocytic, Acute
7
Hodgkin Disease
7
Carcinoma, Non-Small-Cell Lung
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Ovarian Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
6
Anemia, Refractory, with Excess of Blasts
6
Neoplasm Metastasis
5
Lymphoma
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Biphenotypic, Acute
5
Lymphoma, Non-Hodgkin
4
Lung Neoplasms
4
Interventions
spartalizumab
1
sapropterin
1
penpulimab
1
niraparib
1
anlotinib
1
Taxes
1
Leucovorin
1
Ipilimumab
1
IFL protocol
1
Gemcitabine
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma Metastatic
×
Decitabine
×
Clear all
NCT05360264
2025-03-24
ORIENTATE
Regina Elena Cancer Institute
Phase 2
Terminated
7 enrolled